Ubiquigent

#Collaboration #Partnership #Ubiquigent #Ubiquitin-proteasome #University of Glasgow

Industry-academia partners to exploit USP30 as a therapy target

Ubiquigent is supporting a Master’s student at the University of Glasgow (UoG) to undertake a research project on USP30, a (de)ubiquitylation (DUB) implicated in neurodegenerative, renal, and cardiovascular diseases.   Overseen by Professor Helen Walden, UoG, and Dr Mehmet Gundogdu, Principal Scientist at Ubiquigent, the project aims to… Read More

#News